Press Releases

Managing intellectual property more efficiently with leading data and expertiseLONDON, June 15, 2026 /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today that Mitsubishi Fuso Truck and Bus Corporation has selected IPfolio as its intellectual property (IP) management solution. IPfolio provides Mitsubishi Fuso with a modern, scalable foundation for IP management, bringing together trusted data, expert support, and integrated services in a single platform. This will enable greater operational confidence and clearer, more informed decision-making across the IP lifecycle. Keni

SALT LAKE CITY, June 15, 2026 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (NASDAQ:RCAT) ("Red Cat" or the "Company"), a U.S.-based provider of advanced all-domain drone and robotic solutions for defense and national security, today introduced Hellcat™, a dual-use small unmanned aircraft system (sUAS) built on the proven Black Widow™ platform and designed for rapidly evolving operational environments. Red Cat is unveiling Hellcat in conjunction with Eurosatory 2026, where defense leaders, government buyers, and industry partners from across Europe and allied nations are convening to evaluate current and future capabilities with a focus on small UAS, contested-environment operations, and i

SHELL PLC FIRST QUARTER 2026 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS June 15, 2026 The Board of Shell plc today announced the pounds sterling and euro equivalent dividend payments in respect of the first quarter 2026 interim dividend, which was announced on May 7, 2026 at US$0.3906 per ordinary share. Shareholders have been able to elect to receive their dividends in US dollars, euros or pounds sterling. Holders of ordinary shares who have validly submitted US dollars, euros or pounds sterling currency elections by June 8, 2026 will be entitled to a dividend of US$0.3906, €0.3381 or 29.18p per ordinary share, respectively. Absent any valid election to the contrary, persons holding the

CHARLOTTE, North Carolina, June 15, 2026 (GLOBE NEWSWIRE) -- Magnera Corporation (NYSE:MAGN) today announced the sale of its Caerphilly, UK operations to Polyart Group, a Prudentia Capital holding. Following a strategic portfolio review of its manufacturing technologies, products, and markets served, Magnera initiated an evaluation of strategic alternatives for its Caerphilly business that produces metallized paper for various end market applications, including premium labels, gift wrap and food packaging. The evaluation initiated a sale process for the operations, resulting in an agreement with the Polyart Group to purchase 100% of the shares of the Caerphilly business. "We are deeply g

HOUSTON, June 15, 2026 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE:EGY, LSE: EGY)) ("Vaalco" or the "Company") announced positive operational updates offshore Gabon regarding the ongoing drilling program, including impressive initial well results on the Ebouri-5H well and mobilization of the rig to the SEENT platform. Additionally, the Company provided a positive update on the first well completed in the 2026 onshore Egypt drilling program. Operational Highlights: Successfully drilled, completed and placed on production the Ebouri-5H development well at the top of the structure with a lateral of 300 meters of net pay in high-quality Gamba sands; Achieved excellent initial flow ra

Supporting planned growth in InP silicon photonics technologyResolving all prior IP disputes between the companies CARDIFF, UK, and MIGDAL HAEMEK, Israel, June 15 2026 - IQE plc (AIM: IQE, "IQE" or the "Group"), the leading global supplier of compound semiconductor wafer products and advanced material solutions, and Tower Semiconductor (NASDAQ/TASE: TSEM), the leading foundry for high-value analog semiconductor solutions, are pleased to announce a multi-year agreement for the supply of Indium Phosphide (InP) epiwafers for optical connectivity solutions serving AI-driven data centre infrastructure. IQE's InP epiwafers will be used in several of Tower's advanced silicon photonics platforms f

Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcuity into one of the largest molecular biology application areas Expanded Cell and Gene Therapy offerings and workflow automation capabilities strengthen the QIAcuity digital PCR ecosystem New software capabilities support standardized analysis and reporting across digital PCR workflows QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced new additions to its QIAcuity digital PCR (dPCR) ecosystem, with a focus on expanding gene expression capabilities, broadening assay content and enhancing workflow standardization to support the growing adoption of dPCR across li

Strategic collaboration enables merchants and financial intermediaries across Europe to offer Wero as a new payment method to consumers and businesses. ACI Worldwide (NASDAQ:ACIW), an original innovator in global payments technology, has joined the European Payments Initiative (EPI) as a principal member and will integrate EPI's Wero wallet solution onto ACI's best-in-class Payments Orchestration Platform. Through this strategic collaboration, merchants and financial intermediaries across Europe will be able to offer Wero as a new payment method to consumers and businesses. Wero is a pan-European digital wallet solution that runs on SEPA instant payment rails. It aims to unify and strea

World Liberty Financial to Create $250,000 Athlete Bonus Pool for Performance of the Night Winners UFC®, the world's premier mixed martial arts organization, today announced that World Liberty Financial (WLFI), an American financial technology company building products at the intersection of decentralized and traditional finance, will join as an Official Partner of UFC® FREEDOM 250, the historic event taking place on the grounds of the White House in Washington, D.C., this Sunday, June 14. World Liberty Financial will play a key role in UFC® FREEDOM 250 as the Presenting Partner of a new $250,000 Performance of the Night bonus pool, which will be awarded to UFC athletes selected for sta

Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE:TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an a

FF will announce three major highlights on June 16, including introducing multiple new EAI devices, the launch of the world's first Three-in-One EAI robotics education ecosystem and the introduction of more partners, FF Par members, developers, and users who will join us in building the FF EAI education ecosystem. The new devices will include the first full-size humanoid robot in the U.S. to natively support the NVIDIA Sonic full-body motion control system for humanoid robots, the first foundational EAI learning quadruped robot in the U.S., and teaser appearances of FF Master Mini and FF Nova robots. Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future", "FF" or th

Poster presentations from ongoing clinical trials of two core assets, olverembatinib and lisaftoclax, highlight global innovation capabilities in hematologic malignancies ROCKVILLE, Md. and SUZHOU, China, June 14, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ:AAPG, HKEX: 6855)), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies to address unmet medical needs in cancer, announced today that seventeen clinical updates from its core assets were presented at the 31st Congress of the European Hematology Association (EHA2026), including eight poster presentations. The presentati

Crews in final stages of repairs following worst storms since 2020 and remain committed to completing service restoration for all customers ComEd crews have nearly completed the restoration of power to customers impacted by multiple rounds of severe storms that moved through northern Illinois beginning Wednesday afternoon. With 99% of affected customers now restored, crews are in the final stages of repairs and remain committed to completing service restoration for all remaining customers. Multiple bands of severe weather moved through ComEd's northern Illinois service territory on Wednesday and Thursday, bringing intense rain, frequent lightning, and high wind gusts — with speeds reach

CEL-SCI Corporation ("CEL-SCI" or the "Company") (NYSE:CVM), a clinical stage cancer immunotherapy company, today announced the pricing of a best-efforts offering of 2,500,000 shares of common stock at an offering price of $1.00 per share. Total gross proceeds from the offering, before deducting the placement agent's fees and offering expenses, are expected to be $2.5 million. The offering is expected to close on June 16, 2026, subject to satisfaction of customary closing conditions. The Company intends to use the proceeds for the continued development of Multikine*, general corporate purposes, and working capital. ThinkEquity is acting as the sole placement agent for the offering. Th

ZW191 demonstrates compelling anti-tumor activity in platinum-resistant ovarian cancer patients regardless of FRα expression levelConfirmed objective response rate (cORR) of 78.6% in FRα-positive (≥75% at PS2+) platinum-resistant ovarian cancer patients and 47.4% in FRα-negative patients (<75% at PS2+) across all dose levels studiedMedian duration of response was not reached at the time of data cutoff, and median progression-free survival was 7.6 months across ovarian and endometrial cancer cohortsPatient recruitment in dose optimization cohorts completed, with favorable tolerability profile and broad therapeutic window supporting continued clinical development VANCOUVER, British Columbia,

As European and allied forces accelerate modernization efforts in response to evolving operational threats, Oshkosh Defense LLC, an Oshkosh Corporation (NYSE:OSK) business, will showcase proven tactical mobility solutions at Eurosatory 2026 designed to support interoperability, distributed operations and future battlefield requirements, without the risk and long development timelines of entirely new vehicle programs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614504023/en/Oshkosh Defense Hybrid Electric Joint Light Tactical Vehicle (eJLTV). For decades, Oshkosh Defense has supported allied military forces with heavy, medi

- Cohort 1 results presented at ENDO 2026 demonstrate meaningful reductions in total heterotopic ossification (HO) lesion volume, new HO lesions and flare activity in adolescents and adults with FOP - U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for zilurgisertib in FOP under Priority Review Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) and Incyte (NASDAQ:INCY) today announced pivotal Phase 2 results from Cohort 1 of the PROGRESS study evaluating zilurgisertib, an investigational oral activin receptor-like kinase 2 (ALK2) inhibitor, in adolescents and adults (≥12 years of age) with fibrodysplasia ossificans progressiva (FOP). Results were shared in a late-

Data show investigational atumelnant drove sustained androgen reductions while enabling lowering of glucocorticoid supplementation to physiologically normal levels in adults with classic CAH New results from the Phase 1b/2a ACTH-dependent Cushing's syndrome trial also presented, showing atumelnant rapidly lowered early morning cortisol and normalized urinary free cortisol levels even at lower dose SAN DIEGO, June 14, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) presented data today from the open-label, Phase 2 congenital adrenal hyperplasia (CAH) adult study of investigational atumelnant, a novel, once-daily oral adrenocorticotropic hormone (ACTH) receptor antag

Data from up to two years of treatment in PATHFNDR-1 and PATHFNDR-2 open-label extension studies show PALSONIFY maintained lower IGF-1 levels and stable symptoms Treatment also resulted in stable or reduced pituitary tumor volumes for up to 48 weeks Additional ENDO highlights include long-term ACROBAT data demonstrating PALSONIFY and cabergoline combination improves biochemical control of acromegaly SAN DIEGO, June 14, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) today announced new long-term data from its clinical development program evaluating novel PALSONIFYTM (paltusotine) in acromegaly during an oral presentation at the Endocrine Society's Annual Meeting,

Lightweight uncrewed ground vehicle expands mission flexibility for highly mobile units operating in complex and contested environments AeroVironment, Inc. ("AV"), a global leader in autonomous systems, today announced the launch of TOM 50 RE, a compact, backpackable uncrewed ground vehicle (UGV) developed by its wholly owned subsidiary Telerob. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615133056/en/AV's TOM 50 RE backpackable UGV delivers rapid reconnaissance, explosive ordnance disposal, and autonomous mapping capabilities for dismounted forces operating in contested environments. (Photo: AV) Designed for mobile expl